113
Views
0
CrossRef citations to date
0
Altmetric
Original Research

No Relationship Between the International Prostate Symptom Score and Post-Void Residual Volume in Primary Care

ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 167-174 | Published online: 05 May 2020

References

  • National Institute for Health and Care Excellence. Clinical guideline(CG97). Lower Urinary Tract Symptoms in Men: Management. 6 2015.
  • NVU: Richtlijn diagnostiek en behandeling van LUTS-BPH (Dutch Association of Urology: guideline for diagnostics and treatment of LUTS-BPH). 2006.
  • Chapple CR, Wein AJ, Abrams P, et al. Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol. 2008;54(3):563–569. doi:10.1016/j.eururo.2008.03.10918423969
  • Lepor H. Pathophysiology of lower urinary tract symptoms in the aging male population. J Urol. 2005;7:S3–S11.
  • Blanker MH, Breed SA, van der Heide WK, et al. NHG-standaard Mictieklachten bij mannen (Dutch College of general practitioners-guideline: micturition symptoms in men). Huisarts Wet. 2013;56:114–122.
  • Bosch JL, Hop WC, Kirkels WJ, Schroder FH. The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol. 1995;75(5):622–630. doi:10.1111/bju.1995.75.issue-57542132
  • Wolfs GG, Knottnerus JA, Janknegt RA. Prevalence and detection of micturition problems among 2734 elderly men. J Urol. 1994;152:1467–1470. doi:10.1016/S0022-5347(17)32447-37933185
  • Wolters R, Wensing M, van Weel C, van der Wilt GJ, Grol RP. Lower urinary tract symptoms: social influence is more important than symptoms in seeking medical care. BJU Int. 2002;90(7):655–661. doi:10.1046/j.1464-410X.2002.02996.x12410742
  • Shim SR, Kim JH, Kim KH, et al. Association between the self-perception period of lower urinary tract symptoms and the international prostate symptom score. Urol Int. 2012;88(4):431–437. doi:10.1159/00033491322414894
  • Ward J, Sladden M. Urinary symptoms in older men, their investigation and management: is there an epidemic of undetected morbidity in the waiting room? Fam Pract. 1994;11(3):251–259. doi:10.1093/fampra/11.3.2517531166
  • Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67(6):1099–1109. doi:10.1016/j.eururo.2014.12.03825613154
  • Rosenberg MT, Staskin DR, Kaplan SA, MacDiarmid SA, Newman DK, Ohl DA. A practical guide to the evaluation and treatment of male lower urinary tract symptoms in the primary care setting. Int J Clin Pract. 2007;61(9):1535–1546. doi:10.1111/ijcp.2007.61.issue-917627768
  • Dijsterbloem DALA, Schouten MA, Lagro-Janssen ALM. Benigne prostaathypertrofie in 4 huisartsenpraktijken. Voorkomen, beleid en beloop. (Benign prostatic hyperplasia in four general practices. Prevalence, policy and course). Huisarts Wet. 2003;46(3):133–137.
  • Barry MJ, Fowler FJ Jr, O’Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–1557.1279218
  • Szeto PS. Application of the Chinese version of the international prostate symptom score for the management of lower urinary tract symptoms in a primary health care setting. Hong Kong Med J. 2008;14(6):458–464.19060345
  • Ezz el Din K, Kiemeney LA, de Wildt MJ, Debruyne FM, de la Rosette JJ. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the international prostate symptom score. J Urol. 1996;48(3):393–397. doi:10.1016/S0090-4295(96)00206-3
  • Singla S, Garg R, Singla A, Sharma S, Singh J, Sethi P. Experience with uroflowmetry in evaluation of lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Clin Diagn Res. 2014;8(4):Nc01–Nc03. doi:10.7860/JCDR/2014/7909.4271
  • Kelly CE. Evaluation of voiding dysfunction and measurement of bladder volume. Rev Urol. 2004;6(Suppl 1):S32–S37.
  • Chapple CR, Tubaro A. Male LUTS/BPH Made Easy. London: Springer-Verlag; 2014.
  • Ouslander JG, Wood AJJ. Management of overactive bladder. N Engl J Med. 2004;350(8):786–799. doi:10.1056/NEJMra03266214973214
  • Park HJ, Won JEJ, Sorsaburu S, Rivera PD, Lee SW. Urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and LUTS/BPH with erectile dysfunction in Asian men: a systematic review. World J Men's Health. 2013;31(3):193–207. doi:10.5534/wjmh.2013.31.3.19324459652
  • Wang JY, Liu M, Zhang YG, et al. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey. Chin Med J (Engl). 2008;121(20):2042–2045. doi:10.1097/00029330-200810020-0001819080272
  • Tubaro A, Vecchia C. The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey. Eur Urol. 2004;45:767–772. doi:10.1016/j.eururo.2004.01.01115149750